Fonar Corp (FONR)
16.83
-0.17
(-1.00%)
USD |
NASDAQ |
Jun 02, 16:00
17.00
+0.17
(+1.01%)
After-Hours: 20:00
Fonar Cash from Financing (TTM): -7.298M for March 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2023 | -7.298M |
December 31, 2022 | -6.790M |
September 30, 2022 | -6.534M |
June 30, 2022 | -5.860M |
March 31, 2022 | -5.804M |
December 31, 2021 | -5.782M |
September 30, 2021 | -6.311M |
June 30, 2021 | -6.610M |
March 31, 2021 | -4.687M |
December 31, 2020 | -4.688M |
September 30, 2020 | -4.528M |
June 30, 2020 | -4.905M |
March 31, 2020 | -6.970M |
December 31, 2019 | -6.676M |
September 30, 2019 | -6.638M |
June 30, 2019 | -6.622M |
March 31, 2019 | -6.471M |
December 31, 2018 | -7.092M |
September 30, 2018 | -6.201M |
June 30, 2018 | -6.300M |
March 31, 2018 | -7.225M |
December 31, 2017 | -7.900M |
September 30, 2017 | -9.477M |
June 30, 2017 | -10.88M |
March 31, 2017 | -14.80M |
Date | Value |
---|---|
December 31, 2016 | -14.42M |
September 30, 2016 | -13.86M |
June 30, 2016 | -12.49M |
March 31, 2016 | -9.071M |
December 31, 2015 | -13.39M |
September 30, 2015 | -13.27M |
June 30, 2015 | -13.50M |
March 31, 2015 | -13.80M |
December 31, 2014 | -9.666M |
September 30, 2014 | -10.32M |
June 30, 2014 | -10.48M |
March 31, 2014 | 10.75M |
December 31, 2013 | 25.72M |
September 30, 2013 | 27.84M |
June 30, 2013 | 29.59M |
March 31, 2013 | 10.23M |
December 31, 2012 | -3.236M |
September 30, 2012 | -3.306M |
June 30, 2012 | -3.405M |
March 31, 2012 | 4.421M |
December 31, 2011 | 4.607M |
September 30, 2011 | 4.791M |
June 30, 2011 | 5.250M |
March 31, 2011 | -0.5813M |
December 31, 2010 | -0.0993M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-7.298M
Minimum
Mar 2023
-4.528M
Maximum
Sep 2020
-6.138M
Average
-6.391M
Median
Cash from Financing (TTM) Benchmarks
XWELL Inc | -13.46M |
ProPhase Labs Inc | -17.12M |
Applied DNA Sciences Inc | -- |
OncoCyte Corp | 36.13M |
Exagen Inc | -0.521M |